Dominic Stockey Appointed Executive Vice President at Pathology Ventures
Pathology Ventures, LLC (PVL), a physician-founded network representing over 500 pathologists, has appointed Dominic Stockey as its executive vice president. In this role, Stockey will lead the company's partnerships with pharmaceutical and diagnostic sponsors to expand biomarker standards across pathology practices. He brings seven years of investment banking experience in healthcare transactions including M&A and capital formation. PVL was founded in 2025 by three physicians who aim to provide a collaborative platform for pathologists without requiring them to relinquish ownership. Stockey will focus on building industry partnerships that align with PVL's mission while ensuring member practice independence. He will be available at the College of American Pathologists annual meeting, CAP26 in Las Vegas from October 3–6. PVL connects pathology practices with pharmaceutical and research organizations to advance biomarker standardization and digital pathology programs. Stockey’s appointment is expected to enhance PVL's ability to deliver scalable industry solutions while maintaining clinical independence for its members.
